瑞士羁押场所扩展丙肝筛查与直接抗病毒药物治疗的成本效果模型
研究在瑞士羁押场所构建5年决策树筛查模型与马尔可夫治疗结局模型,比较全面筛查所有在押人员与现行基于风险问卷筛查的成本效果。
要点
- 检测比例预计从13.6%升至67.0%,概率敏感性分析成本效果概率为82.3%。
核心结论
- 在瑞士羁押场所,全面筛查所有在押人员并治疗丙肝相比现行基于风险问卷的筛查策略具有成本效果。
研究设计与样本
- 研究从瑞士医疗服务提供者角度开展成本效果分析,将5年决策树筛查模型与丙肝治疗结局马尔可夫模型相结合。
- 模型比较全面筛查所有在押人员与现行基于风险问卷筛查策略,采用标准检测包和单片制剂方案治疗。
- 通过敏感性分析和情景分析考察结果的不确定性。
主要发现
- 全面筛查下检测比例预计从13.6%升至67.0%。
- 概率敏感性分析估计全面筛查具有成本效果的概率为82.3%。
关键数值与推荐
- 瑞士在押人员丙肝患病率估计在5.7%至6.2%之间。
- 检测比例从13.6%升至67.0%,成本效果概率为82.3%。
临床怎么用
- 羁押场所可考虑将丙肝筛查从基于风险问卷的选择性策略扩展为对所有在押人员的全面筛查。
- 全面筛查配合直接抗病毒药物治疗在瑞士支付阈值下具有经济性。
局限性
- 原文未报告模型的具体局限性描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hepatitis C virus (HCV) among people living in detention (PLD) is typically high in many countries including Switzerland, where it is estimated that the HCV prevalence rate is between 5.7% and 6.2%. In Switzerland, the existing screening strategy involves routine screening of PLD who indicate they are from HCV high-risk populations based on questionnaire responses upon entry to the detention center, rather than an offer to screen all PLD. METHODS: A cost-effectiveness analysis from a Swiss healthcare provider perspective was conducted by combining a 5-year decision tree screening model with results from a Markov model of HCV treatment outcomes. This model explored the cost-effectiveness of increased HCV screening to cover all PLD compared to the current approach, using a standard test package and subsequent treatment with a single-tablet regimen in Swiss custodial settings. Sensitivity and scenario analyses examined the uncertainty of results. RESULTS: At the willingness-to-pay threshold of 100 000 Swiss Francs (CHF) per quality-adjusted life-year (QALY), comprehensive general screening was cost-effective compared to current risk-based screening, with a base case incremental cost-effectiveness ratio of CHF 14 312 per QALY. The net monetary benefit of screening the whole PLD population was CHF 23 298 046 and CHF 4298 per person. The proportion of PLD tested was predicted to increase from 13.6% to 67.0% under comprehensive screening. CONCLUSION: The results showed that comprehensive screening strategies in detention centers in Switzerland can be cost-effective, with the probabilistic sensitivity analysis estimating an 82.3% probability of cost-effectiveness.
引用
- Girardin F, Hearmon N, Castro E, et al. Modelling the Impact and Cost-effectiveness of Extended Hepatitis C Virus Screening and Treatment with Direct-acting Antivirals in a Swiss Custodial Setting. Clin Infect Dis. 2019. PMID: 30715266. doi:10.1093/cid/ciz088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。